PPARA and metabolic dysfunction-associated steatohepatitis: miR-34a is upregulated in the liver of patients and rodents with NASH, and its contribution to the development of this disorder appears to occur through mechanisms involving PPARα and SIRT1, which are specific targets of mir-34a [40, 44, 45, 47, 48].